SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-018184
Filing Date
2021-04-08
Accepted
2021-04-08 16:32:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A vktx-defa14a_20210520.htm DEFA14A 25317
2 GRAPHIC g3ymsewzg4dt000001.jpg GRAPHIC 739595
  Complete submission text file 0001564590-21-018184.txt   1044780
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37355 | Film No.: 21815240
SIC: 2834 Pharmaceutical Preparations